Table 2.
Disease recurrence according to demographic and histologic parameters, in 55 patients
| Characteristic | No. of patients out of entire group (%) | No. of patients with recurrent disease (% of each sub group) | Disease recurrence p value | |
|---|---|---|---|---|
|
Age |
<40 |
13 (24%) |
5 (38.5%) |
0.73 |
| 40-59 |
9 (16%) |
4 (44.4%) |
||
| 60-69 |
14 (25%) |
8 (57.1%) |
||
| >70 |
19 (35%) |
10 (52.6%) |
||
|
Gender |
Male |
33 (60%) |
16 (48.5%) |
0.44 |
| Female |
22 (40%) |
12 (54.2%) |
||
|
Pathological type |
Malignant fibrous histiocytoma |
19 (35%) |
12 (66.7%) |
0.67 |
| Liposarcoma |
8 (15%) |
3 (37.5%) |
||
| Leiomyosarcoma |
6 (11%) |
4 (66.6%) |
||
| Angiosarcoma |
2 (4%) |
0 |
||
| Chondrosarcoma |
5(8%) |
1 (20%) |
||
| Synovial sarcoma |
4 (7%) |
3 (75%) |
||
| NOS |
11 (20%) |
5 (45.5%) |
||
|
Grade |
Low |
15 (27%) |
0 |
0.01> |
| Intermediate |
3 (5%) |
1 (33%) |
||
| High |
37 (67%) |
27 (73%) |
||
|
Stage |
I |
18 (33%) |
1 (5.5%) |
0.01> |
| II |
4 (7%) |
3 (75%) |
||
| III |
33 (60%) |
24 (73%) |
||
|
Level of heparanase expression |
No staining |
5 (9%) |
3 (60%) |
|
| Weak staining |
18 (33%) |
10 (55%) |
0.77 |
|
| Strong staining | 32 (58%) | 15 (47%) | ||